P Kenemans|A Bosman - JoVE Visualize

Showing results (241-250 of 322) with videos related to

Pageof 33

Sort By:

British Journal of Obstetrics and Gynaecology|July 30, 1999

An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinomaQ Davies, A C Perkins, J C Roos, et al.

Anticancer Research|November 1, 1991

Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic miceL F Massuger, O C Boerman, F H Corstens, et al.

Development (Cambridge, England)|August 5, 2006

Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levelsErika A Bosman, Kirstie A Lawson, Joke Debruyn, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2003

Investigation of an unexplained skin disorder in a prison clinic in the Netherlands in 2002J G Breugelmans, A Bosman, A K van der Heide, et al.

Gynecologic Oncology|March 1, 1993

HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancerP F van Bommel, A J van den Brule, T J Helmerhorst, et al.

Cancer Research|November 15, 1993

Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patientsM R Buist, P Kenemans, W den Hollander, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 1999

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancerH W Nijman, P Kenemans, R J Poort-Keesom, et al.

European Journal of Clinical Investigation|December 3, 1999

Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion moleculesW M Van Baal, J J Emeis, P Kenemans, et al.

Gynecologic Oncology|January 6, 2000

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.

British Journal of Cancer|June 1, 1993

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesionsF V Cromme, C J Meijer, P J Snijders, et al.

Pageof 33

Showing results (241-250 of 322) with videos related to

Sort By:

Pageof 33

British Journal of Obstetrics and Gynaecology|July 30, 1999

An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinomaQ Davies, A C Perkins, J C Roos, et al.

Anticancer Research|November 1, 1991

Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic miceL F Massuger, O C Boerman, F H Corstens, et al.

Development (Cambridge, England)|August 5, 2006

Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levelsErika A Bosman, Kirstie A Lawson, Joke Debruyn, et al.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2003

Investigation of an unexplained skin disorder in a prison clinic in the Netherlands in 2002J G Breugelmans, A Bosman, A K van der Heide, et al.

Gynecologic Oncology|March 1, 1993

HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancerP F van Bommel, A J van den Brule, T J Helmerhorst, et al.

Cancer Research|November 15, 1993

Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patientsM R Buist, P Kenemans, W den Hollander, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 1999

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancerH W Nijman, P Kenemans, R J Poort-Keesom, et al.

European Journal of Clinical Investigation|December 3, 1999

Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion moleculesW M Van Baal, J J Emeis, P Kenemans, et al.

Gynecologic Oncology|January 6, 2000

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.

British Journal of Cancer|June 1, 1993

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesionsF V Cromme, C J Meijer, P J Snijders, et al.

Pageof 33